Advertisement

Topics

Merus Labs Announces Key Milestone for Sintrom® Profit Enhancing Initiative

14:48 EDT 4 May 2017 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
TORONTO, May 4, 2017 /PRNewswire/ - Merus Labs International Inc. ("Merus" or the "Company") [TSX: MSL, NASDAQ: MSLI] is pleased to announce receipt of full regulatory approval to sell Sintrom® in Spain, our largest market, from their new supply partners....

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Merus Labs Announces Key Milestone for Sintrom® Profit Enhancing Initiative"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.